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ABSTRACT
The International Union of Basic and Clinical
Pharmacology (IUPHAR) database, IUPHAR-DB
(http://www.iuphar-db.org) is an open access,
online database providing detailed, expert-driven
annotation of the primary literature on human and
rodent receptors and other drug targets, together
with the substances that act on them. The present
release includes information on the products of
646 genes from four major protein classes
(G protein-coupled receptors, nuclear hormone
receptors, voltage- and ligand-gated ion channels)
and 3180 bioactive molecules (endogenous
ligands, licensed drugs and key pharmacological
tools) that interact with them. We have described
previously the classification and curation of data
for small molecule ligands in the database; in this
update we have annotated 366 endogenous peptide
ligands with their amino acid sequences, post-
translational modifications, links to precursor
genes, species differences and relationships with
other molecules in the database (e.g. those
derived from the same precursor). We have also
matched targets with their endogenous ligands
(peptides and small molecules), with particular at-
tention paid to identifying bioactive peptide ligands
generated by post-translational modification of
precursor proteins. Other improvements to the data-
base include enhanced information on the clinical
relevance of targets and ligands in the database,
more extensive links to other databases and a
pilot project for the curation of enzymes as drug
targets.
INTRODUCTION
The International Union of Basic and Clinical
Pharmacology (IUPHAR) database, IUPHAR-DB
(http://www.iuphar-db.org/), is now in its 10th year
(1,2), and provides expert-driven, manually curated anno-
tation of the pharmacological, physiological and genetic
properties of human and rodent receptors and other drug
targets, together with the substances that act on them.
Developed under the auspices of the IUPHAR
Committee on Receptor Nomenclature and Drug
Classiﬁcation (NC-IUPHAR), IUPHAR-DB is an au-
thoritative reference and educational resource for pharma-
cologists, clinicians and allied disciplines, receiving over
7000 unique visitors from 115 countries monthly. Here,
we review enhancements to the data content and website
since the last published update (2), including the addition
of information on endogenous ligands of receptors, anno-
tation of structural data for endogenous peptide ligands, a
pilot project to curate enzymes as drug targets, increased
database links and expansion of data on the clinical rele-
vance of targets and ligands in the database.
CONTENT
In its present release, IUPHAR-DB covers the complete
genomic complement of 4 protein superfamilies in human,
rat and mouse: non-sensory G protein-coupled receptors
(GPCRs), nuclear hormone receptors (NHRs), voltage-
gated ion channels (VGICs) and ligand-gated ion channels
(LGICs), as well as pilot data on 10 enzymes (from the
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lanosterol biosynthesis pathway). All data are manually
curated by expert scientists and curators and referenced to
primary literature citations in PubMed (http://www.ncbi
.nlm.nih.gov/pubmed). Information provided about
targets includes their nomenclature, structure, function,
physiology, clinical relevance and key ligands (endogenous
ligands, licensed drugs, pharmacological tools and radio-
ligands). Targets are linked to genomic databases such as
Entrez Gene (3), Ensembl (4) and OMIM (Online
Mendelian Inheritance in Man) (5), protein databases
such as UniProt (6) and specialist pharmacological andme-
dicinal chemistry databases such as DrugBank (7) and
ChEMBL (8). The database presently includes information
on over 8000 interactions between these targets and 3180
small molecules, natural products, peptides and inorganic
compounds. Database pages for ligands provide informa-
tion on their structures, physicochemical properties,
synonyms, binding afﬁnities and actions at targets, lists of
similar substances and links to chemistry databases
including PubChem (9), ChemSpider (10) and Chemical
Entities of Biological Interest (ChEBI) (11). All data are
subject to yearly review and updated as required to reﬂect
advances in the ﬁeld. Table 1 lists the receptor and ion
channel database pages that have been updated since the
last published report (2).
NEW FEATURES
Annotation of endogenous ligands
IUPHAR-DB target pages list ligands recommended for
experimental use including endogenous ligands, synthetic
drugs and radiolabelled forms, together with their actions
and quantitative data. Since the lists can be quite exten-
sive, NC-IUPHAR is working to identify a subset of
ligands with optimal properties for preclinical and trans-
lational research. A crucial ﬁrst step is to identify the prin-
cipal endogenous ligands with activity at targets. To this
end IUPHAR-DB curators have identiﬁed through litera-
ture and database searches 863 endogenous ligands for
GPCRs and NHRs, and highlighted these on target
pages together with additional comments. Likewise, the
database pages for endogenous ligands clearly identify
their natural targets under the ‘Biological Activity’ tab.
Linking endogenous small molecule ligands such as
monoamines to their cognate receptors was straightfor-
ward because most were already described in IUPHAR-
DB. However, the task proved more challenging for
peptides due to the difﬁculty in distinguishing between
endogenous peptides synthesized by post-translational
processing of polypeptide precursors and peptide frag-
ments produced synthetically in order to study struc-
ture–activity relationships. It can be very difﬁcult to
prove the existence, or otherwise, of particular peptide
fragments in vivo, many of which may be present at only
low concentrations, in distinct tissues or under speciﬁc
physiological conditions. As a result there is a disjunction
between sequences listed in online protein databases and
information in the literature on their activities at targets.
We sought to bridge this divide by annotating endogenous
peptides described in pharmacological literature with
structural information and by deﬁning their relationships
with other peptides. Endogenous ligands were identiﬁed
Table 1. IUPHAR-DB receptor and ion channel pages that have been updated since the last published database report
Receptor family Details Date of public release
Dopamine Annotation added August 2010
Formylpeptide Annotation added August 2010
Leukotriene Annotation added August 2010
Motilin Annotation added August 2010
Tachykinin Annotation added August 2010
Vasopressin and oxytocin Annotation added August 2010
Hydrocarboxylic acid Annotation added February 2011
Lysophospholipid Annotation added February 2011
Frizzled Annotation added (FZD3 and FZD4) February 2011
Orphan GPCRs Annotation added (GPR39, LPAR6, GPR35, GPR87 and P2RY10) February 2011
Ionotropic glutamate Annotation added (GluA2) February 2011
GABAA Annotation added (d,e,y,p) February 2011
P2X Annotation added (P2X7) February 2011
P2X Annotation added (P2X3) May 2011
GABAA Annotation added (b2,g3) May 2011
Nicotinic acetylcholine Annotation of all subunits September 2011
VIP and PACAP Updated September 2011
a-adrenoceptors Updated February 2012
b-adrenoceptors Updated February 2012
Calcitonin Updated February 2012
Calcium sensing Updated February 2012
Cannabinoid Updated February 2012
Orexin Updated February 2012
GABAA Updated (a3,a4,a5,b3,g1,g2,d,e,y) February 2012
Neuropeptide FF/neuropeptide AF Updated July 2012
Neurotensin Updated July 2012
Vasopressin and oxytocin Updated July 2012
P2X Updated (P2X3) July 2012
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through detailed reviews of the literature and interroga-
tion of sequence databases such as UniProt. In total, 366
distinct endogenous peptide sequences were identiﬁed as
ligands of human, rat and mouse GPCRs.
Reorganized ligand classiﬁcation
The IUPHAR-DB ligand classiﬁcation has been
reorganized. The ‘Peptide’ category is now divided into
‘Endogenous Peptides’ and ‘Other Peptides’. For this
purpose, endogenous peptides were deﬁned as peptides
encoded in the genomes of the three species covered by
IUPHAR-DB, human, rat and mouse. All other peptides
including synthetic peptides, semi-synthetic modiﬁed
forms and peptides endogenous to other species (e.g.
conotoxins) are now classiﬁed as ‘Other Peptides’.
Endogenous small molecules such as hormones, neuro-
transmitters and metabolites have been placed into a
category named generally as ‘Metabolites’ (formerly
‘Small Organics’), which also includes very close ana-
logues such as radiolabelled forms. All other synthetic
compounds may be found under the ‘Synthetic Organics’
category.
Enhanced peptide information
In the last published update (2) we described the curation
of structural information and descriptors for 2000 small
molecule ligands in IUPHAR-DB. This information has
now been enhanced by the curation of structural data for
the 366 human, rat and mouse endogenous peptide se-
quences described earlier. For each endogenous peptide
ligand, a range of information has been collected,
including nomenclature, single- and three-letter amino
acid sequences, post-translational modiﬁcations,
encoding genes and precursor proteins for human, rat
and mouse. Where the mature peptide was identical in
structure between species, the information on all the
encoding genes and precursor proteins was collated
under the same database entry (Figure 1A). Where the
mature peptide differed in sequence between species,
separate database entries where created for each species
with the relevant structural, precursor and genetic infor-
mation included. Database links are provided to genetic,
protein and chemistry databases including the HUGO
Gene Nomenclature Committee (HGNC) database (12),
Rat Genome Database (RGD) (13), Mouse Genome
Database (MGD) at the Mouse Genome Informatics
(MGI) website (14), Ensembl, UniProt, PubChem,
ChEBI, and, where available, to experimental 3D struc-
tures in the RCSB Protein Data Bank (15).
In some cases, IUPHAR-DB also provides information
on endogenous peptides in species other than human,
mouse and rat where these are commonly used as experi-
mental tools at human or rodent targets. Ambiguities in
Figure 1. Panel (A) shows a screenshot of the ligand page for the en-
dogenous peptide orexin-A open at the ‘Summary’ tab. The sequence of
orexin-A is identical in human, mouse and rat so the information on
this peptide is grouped into a single database entry. Panel (B) shows a
screenshot of the LH b subunit ligand page, open at the ‘Structure’ tab
and showing the peptide sequence, post-translational modiﬁcations and
a link to the ligand page for the LH heterodimer. Panel (C) shows a
screenshot of the ligand page for vasoactive intestinal peptide (VIP),
Figure 1. Continued
open at the ‘Similar Ligands’ tab. The ‘Related Sequences’ table lists
other peptides derived from the same precursor or orthologues in other
species, whereas the ‘Other Similar Sequences’ table lists other peptides
that have similar sequences to VIP, including synthetic and modiﬁed
forms of VIP.
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the literature on the peptide hormone secretin illustrate
the need for this work. Secretin was ﬁrst isolated from
the pig and porcine secretin is frequently used in assays
of secretin receptor function, even though it differs in
amino acid sequence from the endogenous human and
rodent peptides (16). Re-evaluation of the literature on
secretin in the course of this project enabled us to
provide separate data on the activities of pig, human
and rodent secretins.
Some hormones are formed by the covalent association
of multiple peptide fragments of a single polypeptide pre-
cursor (e.g. the A and B chains of insulin (17) and related
hormones). In other cases, polypeptide subunits encoded
by more than one gene combine to form the active ligand;
the exact combination can determine target speciﬁcity.
For example, the glycoprotein hormones follicle-
stimulating hormone (FSH), thyroid-stimulating
hormone (TSH), luteinizing hormone (LH) and human
chorionic gonadotropin (hCG) all share a common a
subunit with different b subunits conferring their target
speciﬁcity (18). The database now supports multi-subunit
polypeptide ligands, with distinct entries created for the
intact hormone and for each component polypeptide
chain. Cross-links between functional ligand and compo-
nent subunit pages are provided via the ‘Structure’ tab.
Sequence and precursor information is provided under
the subunit entry (e.g. LH b subunit, Figure 1B) and bio-
logical activity data can be found on the page for the
functional ligand (e.g. LH).
A new ‘Related Sequences’ table has been added to en-
dogenous peptide pages, which lists other peptides in the
database that have the same parent precursor polypeptide,
as well as corresponding peptides from other species. The
‘Other Similar Sequences’ table lists additional endogenous
and synthetic peptides with similar sequences, identiﬁed by
clustering with the h-cd-hit program, part of the CD-HIT
Suite (19). Together, these tables allow users to easily
identify similar peptides in the database without any
prior knowledge of their structures (Figure 1C).
Overall, this is a unique resource bringing together en-
dogenous peptide sequences with quantitative data on
their actions at targets, which complements detailed struc-
tural data available in UniProt, and pathway information
available in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) (20). Work is currently under way to
curate sequence and structural information on modiﬁed
peptides containing non-natural amino acids,
pseudo-peptide bonds, and/or cyclization and link these
to activity data in IUPHAR-DB.
Clinical relevance of drugs and targets
Information on the clinical relevance of targets and ligands
in IUPHAR-DB has been enhanced by the addition of data
on the status and nomenclature of approved drugs. By
matching structures to entries in DrugBank, 300 small
molecule drugs with United States Food and Drug
Administration (FDA) approval for clinical use in
humans, and 6 drugs now withdrawn from clinical use,
were identiﬁed and marked as ‘approved’ or ‘withdrawn’,
respectively. DrugBank includes a range of useful data on
clinically used drugs such as indication, mechanism of
action, absorption, metabolism, toxicity, drug–drug and
drug–target interactions. Links are provided to
DrugBank target pages and DrugBank chemical classiﬁca-
tions and drug page links provided for ligands. Structure-
based searching also enabled us to assign International
Nonproprietary Names (INNs) to 420 of the ligands in
IUPHAR-DB. INNs are the ofﬁcial non-proprietary or
generic names given to pharmaceutical substances, as
designated by the World Health Organization (WHO).
A collaboration with Orphanet, the portal for rare
diseases and orphan drugs (21), has led to the addition
of data on rare diseases which are associated with
targets in IUPHAR-DB. Each rare disease listing in
IUPHAR-DB includes a brief description and links to
expert-curated summaries in OMIM and Orphanet.
Radiolabelled analogues
Information on assays involving radiolabelled ligands can
be difﬁcult to ﬁnd in literature as labelled forms are not
often mentioned in abstracts. IUPHAR-DB ligand pages
now feature a quick way to identify radiolabelled forms
described in the database via a new ‘Radio Analogues’ tab.
Labelled ligands are linked to relevant literature refer-
ences, accessible via a ‘References’ tab on ligand pages.
This feature provides a useful complement to a longer
list of structurally similar ligands that may be found
under the ‘Similar Ligands’ tab along with links to their
targets.
Enzymes as drug targets
As a pilot study for the future curation of enzymes as drug
targets in IUPHAR-DB, we have curated data for the 10
enzymes of the lanosterol biosynthesis pathway, including
HMG-CoA reductase, the rate-limiting enzyme in choles-
terol synthesis and the target of the statin drugs used to
treat hypercholesterolemia. Information provided about
enzymes includes structural and genomic data, catalysed
reactions, Enzyme Commission (EC) numbers, kinetic
data, substrates, cofactors, selected inhibitors and their
afﬁnities. Links are provided to other databases including
BRENDA, the Comprehensive Enzyme Information
System (22), the International Union of Biochemistry
and Molecular Biology (IUBMB) Enzyme Nomenclature
Database (http://www.chem.qmul.ac.uk/iubmb/enzyme/)
and KEGG. The information in IUPHAR-DB comple-
ments that available in enzyme databases such as
BRENDA, which organizes enzymes by EC number
across the tree of life, and bioactivity databases such as
ChEMBL, which catalogues the results of published me-
dicinal chemistry screens. The IUPHAR-DB approach is
focussed on curation of data relevant to individual
enzymes as human drug targets.
New database links
New database links have been provided from target pages
to Ensembl, a genomic database, DrugBank, a database of
drugs and their targets, Orphanet, the portal for rare
diseases and orphan drugs, InterPro (23), a protein signa-
ture database, ChEMBL, a database of bioactive drug-like
D1086 Nucleic Acids Research, 2013, Vol. 41, Database issue







small molecules from medicinal chemistry literature, and
TreeFam (24), a database of phylogenetic trees. Ligands
are now linked to DrugBank, ChEMBL, ChemSpider, the
free chemical database from the Royal Society of
Chemistry, BindingDB (25), a database of measured
binding afﬁnities, ZINC (26), a database of commercially
available compounds for virtual screening, and the
Human Metabolome Database (27), a database of small
molecule metabolites in humans. Additional new database
links for endogenous peptide ligands are described above
in the section on ‘Enhanced peptide information’.
Links with Guide to PHARMACOLOGY
NC-IUPHAR has established a collaboration with the
editors and publishers of the British Pharmacological
Society (BPS) Guide to Receptors and Channels
(GRAC) (28) to make IUPHAR-DB data available
through a new portal, Guide to PHARMACOLOGY
(http://www.guidetopharmacology.org). The Guide to
PHARMACOLOGY includes a new open-access
database of information from GRAC and IUPHAR-DB
with search tools and guidelines for pharmacology.
GRAC covers a wider range of targets than
IUPHAR-DB, and for each target lists key selective
ligands and probes, recommended literature references
and expert summaries of their properties. The
IUPHAR-DB website includes links to Guide to
PHARMACOLOGY pages and ligand pages include a
summary of the data in GRAC.
FUTURE PERSPECTIVES
Work is currently under way to curate structural informa-
tion for the last remaining group of ligands in
IUPHAR-DB that currently lack this information: the
696 peptides not endogenous to human, rat and mouse
species, which includes toxins, synthetic, radiolabelled
and modiﬁed peptides. In the near future, we plan to
add a sequence-based search facility for peptides to com-
plement existing structure-based search tools for small
molecules. The range of targets will be expanded to en-
compass all the human targets of current licensed drugs
and those of probable future interest, with initial effort
towards curation of enzymes and receptor tyrosine
kinases. NC-IUPHAR and the BPS are also working
towards better integration between IUPHAR-DB and
GRAC, ensuring consistency of information but retaining
their distinctive focus, with GRAC providing a summary
of the key properties and ligands for a wide range of
targets and IUPHAR-DB providing detailed annotation
for a narrower range of important targets.
DATA ACCESS
IUPHAR-DB is freely available to access online at http://
www.iuphar-db.org. The website includes downloadable
ﬁles containing current receptor and channel lists,
NC-IUPHAR nomenclature, synonyms, genetic informa-
tion, HGNC gene nomenclature and identiﬁers and other
database accessions. Other ﬁle formats are available by
emailing curators@iuphar-db.org. Information on
linking to IUPHAR-DB pages is provided at http://
www.iuphar-db.org/linking.jsp. In the near future, we
plan to enable computational access to the database via
Web services and to extend the range of options for data
download via the website.
CITING IUPHAR-DB
For a general citation of the resource we recommend
citing this article. For citing speciﬁc target pages we
recommend a format similar to the following example:
A. P. Davenport, E. J. Mead. Kisspeptin receptor. Last
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